Table 2.
Name of the compound | Chemical structure | Function | Reference |
---|---|---|---|
Camostat mesylate | Protease inhibitor | [137] | |
PB28 | Replication of SARS-CoV-2 by inhibiting the translation of viral RNA, or by modulation cell signaling | [232], [233] | |
Zotatifin | Replication of SARS-CoV-2 by inhibiting the translation of viral RNA, or by modulation cell signaling | [232], [233] | |
Cloperastine | Antihistamines showed good antiviral properties | [233] | |
Clemastine | Antihistamines showed good antiviral properties | [233] | |
Famotidine (Pepcid) | Targets histamine H2 receptors which are abundant in all parts of the body release of histamine by the mast cells is blocked and the overreaction of immune system dampened |
[234] [235] |
|
Remdesivir | Inhibitors of viral RdRp's | ||
EIDD-2801 (Molnupiravir) | Inhibitors of viral RdRps | [219], [220], [221] | |
Favipiravir | Inhibitors of viral RdRp's | [219], [220], [221] | |
Tautomers of EIDD-1931 | Antiviral against RNA viruses | [189] | |
Dexamethasone | Suppresses the overreaction of the immune system | [236] | |
Hydroxychloroquine | Anti-malarial drug. Inhibits viral replication in vitro Now not recommended for COVID-19 treatment |
[237], [238], [239], [240] | |
Baricitinib | Anti-inflammation rheumatoid arthritis drug Could prevent the cytokine storm |
[241], [242], [243] | |
Ruxolittinib | A cancer drug Could prevent the cytokine storm |
[241], [242], [243] | |
Brensocatib | [231] | ||
Abu-Bip-CN | [231] | ||
IcatCxpz41 | [231] |
Structures created with ChemDraw.